PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Diabetes Research Centre, University Hospitals of Leicester NHS Trust, Leicester General Hospital, Leicester, U.K. kk22@leicester.ac.uk.\', \'Section of Diabetes, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.\', \'Laboratory for Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.\', \'VA Puget Sound Health Care System and University of Washington, Seattle, WA.\', \'Harvard Medical School, Boston, MA.\', \'American Diabetes Association, Arlington, VA.\', \'Division of Endocrinology and Metabolism, University of North Carolina School of Medicine, Chapel Hill, NC.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.2337/dc21-1318
?:doi
?:hasPublicationType
?:journal
  • Diabetes care
is ?:pmid of
?:pmid
?:pmid
  • 34625431
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.693
?:rankingScore_hIndex
  • 319
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19, Hyperglycemia, and New-Onset Diabetes.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all